Recent news on Gastrocrom

Manhattan Pharmaceuticals Announces License Agreement and Expanded ...  -  Apr 5, 2007
Drug Newswire (press release),Oral cromolyn sodium is the active ingredient in Gastrocrom(R) an oral liquid solution that is currently FDA approved for the treatment of mastocytosis.

Azur Pharma Announces the Acquisition of Pharmelle  -  Mar 8, 2007
Drug Newswire (press release),Our existing product, Gastrocrom(R), continues to perform very strongly since it was acquired by Azur in January 2006. The combined business will generate

UCB Full-Year 2006 Financial Results  -  Feb 28, 2007
PharmaLive.com (press release),...impacted by the divestment of the peptides manufacturing business (Bioproducts), the sale of Gastrocrom™, OTC Delsym™ and the return of the Corifeo™

Azur drug firm buys US group Pharmelle for E20m  -  Feb 26, 2007
Biotechnology Ireland,In January 2006, the firm spent $11 million on the acquisition of a product called Gastrocrom, for the treatment of a gastrointestinal disorder known as

Allergy Drug Slows Growth of Pancreatic Tumors  -  Dec 20, 2006
Ivanhoe,New research from the University of Texas MD Anderson Cancer Center reveals cromolyn (Intal, Gastrocrom) significantly slows the growth of pancreatic tumors

Allergy Drug Slows Growth of Pancreatic Tumors  -  Dec 20, 2006
Ivanhoe,New research from the University of Texas MD Anderson Cancer Center reveals cromolyn (Intal, Gastrocrom) significantly slows the growth of pancreatic tumors



Azur Pharma set for US expansion  Apr 22, 2006
Azur Pharma’s first large acquisition was made in January with the purchase of Gastrocrom, a drug used to treat a rare cell disorder called mastocytosis ... - The Sunday Times

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional